Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | STS | P08842 | 2/20 | 0.65 |
| ▸ | GPR119 | Q8TDV5 | 8/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.59 |
| ▸ | TGFBR1 | P36897 | 2/20 | 0.58 |
| ▸ | MMP1 | P03956 | 5/20 | 0.57 |
| ▸ | MMP9 | P14780 | 5/20 | 0.57 |
| ▸ | MMP3 | P08254 | 4/20 | 0.57 |
| ▸ | MMP7 | P09237 | 4/20 | 0.57 |
| ▸ | MMP13 | P45452 | 4/20 | 0.57 |
| ▸ | MMP8 | P22894 | 3/20 | 0.57 |
| ▸ | MMP2 | P08253 | 2/20 | 0.57 |
| ▸ | BACE1 | P56817 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10265584 | 0.88 | GPR119 (0.57) | STSGPR119MMP13 | |
| SCHEMBL15103494 | 0.87 | GPR119 (0.56) | STSGPR119MMP13 | |
| SCHEMBL3034734 | 0.87 | GPR119 (0.56) | STSGPR119TGFBR1 | |
| SCHEMBL24906895 | 0.85 | LMNA (0.64) | ALDH1A1MMP1MMP9MMP3MMP7 | |
| SCHEMBL6011511 | 0.85 | STS (0.56) | STSGPR119ALDH1A1TGFBR1MMP1 | |
| SCHEMBL17942537 | 0.85 | TGFBR1 (0.59) | STSGPR119TGFBR1MMP13 | |
| SCHEMBL29529639 | 0.85 | GPR119 (0.56) | STSGPR119MMP1MMP9MMP3 | |
| SCHEMBL17942413 | 0.85 | GPR119 (0.56) | STSGPR119MMP1MMP9MMP3 | |
| SCHEMBL28514815 | 0.83 | STS (0.68) | STSGPR119ALDH1A1TGFBR1MMP1 | |
| SCHEMBL17942308 | 0.82 | GPR119 (0.54) | STSGPR119 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210147360-A1 | SSAO INHIBITORS AND USE THEREOF | ECCOGENE INC. | 2021-05-20 | — | — | US | disclosed |
| WO-2021083209-A1 | SSAO INHIBITORS AND USE THEREOF | ECCOGENE (SHANGHAI) CO., LTD. (CN) | 2021-05-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210147360-A1 | SSAO INHIBITORS AND USE THEREOF | SSB, HAO1, SORD | STS 229/4885GPR119 649/4885ALDH1A1 471/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.